URGENT: Japan’s Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil.
Newsfrom Japan
Economy- English
- 日本語
- 简体字
- 繁體字
- Français
- Español
- العربية
- Русский
Astellas Pharma Inc. said Monday it will buy U.S. pharmaceutical company Iveric Bio Inc. for about $5.9 billion.
The U.S. company, which focuses on ophthalmology treatments, will become Astellas’ wholly owned subsidiary, Astellas said in a release.